Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Buy
68
OHI Quote, Financials, Valuation and Earnings
Last price:
$37.35
Seasonality move
:
10.62%
Day range:
$37.30 - $37.76
52-week range:
$29.66 - $44.42
Dividend yield:
7.17%
P/E ratio:
24.11x
P/S ratio:
9.61x
P/B ratio:
2.32x
Volume:
6.8M
Avg. volume:
2.4M
1-year change:
19.7%
Market cap:
$10.5B
Revenue:
$1.1B
EPS (TTM):
$1.55
Analysts' Opinion
-
Consensus RatingOmega Healthcare Investors has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $41.00, Omega Healthcare Investors has an estimated upside of 9.71% from its current price of $37.37.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $37.00 representing 0.99% downside risk from its current price of $37.37.
Fair Value
-
According to the consensus of 14 analysts, Omega Healthcare Investors has 9.71% upside to fair value with a price target of $41.00 per share.
OHI vs. S&P 500
-
Over the past 5 trading days, Omega Healthcare Investors has underperformed the S&P 500 by -1.17% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Omega Healthcare Investors does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Omega Healthcare Investors has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Omega Healthcare Investors reported revenues of $279.3M.
Earnings Growth
-
Omega Healthcare Investors has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Omega Healthcare Investors reported earnings per share of $0.41.
Enterprise value:
15B
EV / Invested capital:
--
Price / LTM sales:
9.61x
EV / EBIT:
23.42x
EV / Revenue:
14.31x
PEG ratio (5yr expected):
0.43x
EV / Free cash flow:
20.08x
Price / Operating cash flow:
13.49x
Enterprise value / EBITDA:
15.89x
Gross Profit (TTM):
$1B
Return On Assets:
4.37%
Net Income Margin (TTM):
38.65%
Return On Equity:
9.91%
Return On Invested Capital:
4.52%
Operating Margin:
62.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $878.2M | $949.7M | $1.1B | $239.3M | $279.3M | |
| Gross Profit | $862.7M | $934.7M | $1B | $236.1M | $275.9M | |
| Operating Income | $392.3M | $489M | $659.7M | $109M | $175.4M | |
| EBITDA | $1B | $810.8M | $947.1M | $196.9M | $252.5M | |
| Diluted EPS | $1.79 | $0.99 | $1.55 | $0.22 | $0.41 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.8B | $1.8B | $2.2B | $2.6B | |
| Total Assets | $9.5B | $9.6B | $9.4B | $9.1B | $9.9B | |
| Current Liabilities | $382M | $276.7M | $334.3M | $308.2M | $328.2M | |
| Total Liabilities | $5.5B | $5.5B | $5.6B | $5.4B | $5.2B | |
| Total Equity | $4B | $4.1B | $3.8B | $3.8B | $4.7B | |
| Total Debt | $5.2B | $5.3B | $5.3B | $5.1B | $4.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $625.7M | $617.7M | $749.4M | $165M | $229M | |
| Cash From Investing | $442.9M | -$770K | -$671.2M | $111.3M | -$281.7M | |
| Cash From Financing | -$789.4M | -$473.3M | $26.3M | -$389.8M | $243.4M | |
| Free Cash Flow | $625.7M | $617.7M | $749.4M | $165M | $229M | |
OHI
Sector
Market Cap
$10.5B
$1B
Price % of 52-Week High
84.14%
80.57%
Dividend Yield
7.17%
3.32%
Shareholder Yield
-3.76%
3.41%
1-Year Price Total Return
19.7%
-1.78%
Beta (5-Year)
1.003
0.886
Dividend yield:
7.17%
Annualized payout:
$2.68
Payout ratio:
168.69%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$37.53
200-day SMA
Sell
Level
$37.78
Bollinger Bands (100)
Sell
Level
36.74 - 40.16
Chaikin Money Flow
Buy
Level
255.7M
20-day SMA
Buy
Level
$37.08
Relative Strength Index (RSI14)
Buy
Level
51.21
ADX Line
Buy
Level
12.69
Williams %R
Neutral
Level
-45.6522
50-day SMA
Buy
Level
$37.11
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
253.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.342)
Sell
CA Score
(Annual)
Level (-0.455)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.0273)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
Stock Forecast FAQ
In the current month, OHI has received 5 Buy ratings 9 Hold ratings, and 0 Sell ratings. The OHI average analyst price target in the past 3 months is $41.00.
-
Where Will Omega Healthcare Investors Stock Be In 1 Year?
According to analysts, the consensus estimate is that Omega Healthcare Investors share price will rise to $41.00 per share over the next 12 months.
-
What Do Analysts Say About Omega Healthcare Investors?
Analysts are divided on their view about Omega Healthcare Investors share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Omega Healthcare Investors is a Sell and believe this share price will drop from its current level to $37.00.
-
What Is Omega Healthcare Investors's Price Target?
The price target for Omega Healthcare Investors over the next 1-year time period is forecast to be $41.00 according to 14 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is OHI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Omega Healthcare Investors is a Hold. 9 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of OHI?
You can purchase shares of Omega Healthcare Investors via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Omega Healthcare Investors shares.
-
What Is The Omega Healthcare Investors Share Price Today?
Omega Healthcare Investors was last trading at $37.35 per share. This represents the most recent stock quote for Omega Healthcare Investors. Yesterday, Omega Healthcare Investors closed at $37.37 per share.
-
How To Buy Omega Healthcare Investors Stock Online?
In order to purchase Omega Healthcare Investors stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
